Anjum Zafar

482 citations
10 papers · 369 indexed · h-index 9
    • Proteoglycans and glycosaminoglycans research 2
    • Cancer-related molecular mechanisms research 2
    • Genomics and Chromatin Dynamics 2
    • Fibroblast Growth Factor Research 2
    • FOXO transcription factor regulation 2
    • Cancer Cells and Metastasis 4
    • Pancreatic and Hepatic Oncology Research 1
    • HIV Research and Treatment 1

Anjum Zafar

9 papers receiving 367 citations

Peers

Anjum Zafar
Comparison fields: 5 of 59
  • Cell Biology 104
  • Cancer Research 72
  • Molecular Biology 299
  • Oncology 99
  • Immunology 63
Replace Vivian Chua with:
Vivian Chua United States
Saurav De United States
Rachid Lahlil France
Lorena A. Puto United States
Valerie Morris United States
Mary J. Pulvino United States
Matthew J. Simmons United States
Nan Song China
Yu Nishioka Japan
Anjum Zafar relative to Vivian Chua United States Vivian Chua's profile →
Citations per field
00.5×11.5×
Vivian Chua · 1×
Citations per year

Countries citing papers authored by Anjum Zafar

Since Specialization
Citations

This map shows the geographic impact of Anjum Zafar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anjum Zafar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anjum Zafar more than expected).

Fields of papers citing papers by Anjum Zafar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anjum Zafar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anjum Zafar. The network helps show where Anjum Zafar may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Anjum Zafar, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Anjum Zafar Line = papers co-authored together Anjum Zafar links everyone, so they are left out of the graph.

All Works

10 of 10 papers shown
#Work
1 20250
2 2018119
3 20169
4 201617
5 20149
6 201431
7 201360
8 201255
9 201217
10 201152

About Anjum Zafar

Anjum Zafar is a scholar working on Oncology, Virology and Cancer Research, having authored 10 papers that have together received 369 indexed citations. Recurring topics across this work include Cancer Cells and Metastasis (4 papers), Genomics and Chromatin Dynamics (2 papers), Fibroblast Growth Factor Research (2 papers), FOXO transcription factor regulation (2 papers), Cancer-related molecular mechanisms research (2 papers), Proteoglycans and glycosaminoglycans research (2 papers), Pancreatic and Hepatic Oncology Research (1 paper) and HIV Research and Treatment (1 paper). The work is most often cited by research in Cell Biology (104 citations), Cancer Research (72 citations) and Molecular Biology (299 citations). Anjum Zafar has collaborated with scholars based in Australia, United States and Germany. Frequent co-authors include Sudha Rao, Elissa L. Sutcliffe, Christopher R. Parish, Jasmine Li, Kristine Hardy, Yi He, Craig Freeman, Robert McCuaig, Fan Wu and Christopher R. Sutton. Their work appears in journals such as Molecular Cell, Molecular and Cellular Biology and Scientific Reports.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026